Attentional functioning and impulse control in cocaine-exposed and control children at age ten years

Journal of Developmental and Behavioral Pediatrics

Volumn 26, Issue 1, 2005, Pages 42-47

  Savage, Jessica ^a   Brodsky, Nancy L ^b   Malmud, Elsa ^b   Giannetta, Joan M ^b   Hurt, Hallam ^b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c NONE   (United States)

Author keywords

Attentional functioning; Gestational cocaine exposure; Impulse control

Indexed keywords

ALCOHOL; CANNABIS; COCAINE;

ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; COGNITION; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DISTRACTIBILITY; FEMALE; FUNCTIONAL ASSESSMENT; HIGH RISK POPULATION; HUMAN; IMPULSE CONTROL DISORDER; MAJOR CLINICAL STUDY; MALE; PRENATAL EXPOSURE; PRIORITY JOURNAL; PSYCHOLOGIC TEST; SCHOOL; SCHOOL CHILD; TASK PERFORMANCE; TEACHER; TOBACCO; URBAN AREA;

ATTENTION; CASE-CONTROL STUDIES; CHILD; CHILD BEHAVIOR; COCAINE; FEMALE; HUMANS; IMPULSIVE BEHAVIOR; MALE; NEUROPSYCHOLOGICAL TESTS; PHILADELPHIA; POVERTY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; STATISTICS, NONPARAMETRIC;

EID: 15944429305     PISSN: 0196206X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Mayes LC. A behavioral teratogenic model of the impact of prenatal cocaine exposure on arousal regulatory systems. Neurotoxicol Teratol. 2002;24:385-395.
2. Frank DA, Jacobs RR, Beeghly M, et al. Level of prenatal cocaine exposure and scores on the Bayley Scales of Infant Development: modifying effects of caregiver, early intervention, and birth weight. Pediatrics. 2002;110:1143-1152.
3. Hurt H, Brodsky NL, Betancourt L, Braitman LE, Malmud E, Giannetta J. Cocaine-exposed children: follow-up through 30 months. J Dev Behav Pediatr. 1995;16:29-35.
4. Hurt H, Malmud E, Betancourt L, Brodsky NL, Giannetta JM. A prospective comparison of developmental outcome of children with in utero cocaine exposure and controls using the Battelle Developmental Inventory. Dev Behav Pediatr. 2001;22:27-34.
5. Messinger DS, Bauer CR, Das A, et al. The maternal lifestyle study: cognitive, motor, and behavioral outcomes of cocaine-exposed and opiate-exposed infants through three years of age. Pediatrics. 2004; 113:1677-1685.
6. Hurt H, Giannetta J, Brodsky NL, Malmud E, Pelham T. Are there neurologic correlates of in utero cocaine exposure at age 6 years? J Pediatr. 2001;138:911-913.
7. Betancourt LM, Fischer R, Giannetta JM, Malmud E, Brodsky NL, Hurt H. Problem-solving ability of inner-city children with and with-out in utero cocaine exposure. J Dev Behav Pediatr. 1999;20:418-424.
8. Moore TR, Sorg J, Miller L, Key TC, Resnik R. Hemodynamic effects of intravenous cocaine on the pregnant ewe and fetus. Am J Obstet Gynecol. 1986;155:883-888.
9. Woods JR, Plessinger MA, Clark K. Effect of cocaine on uterine blood flow and fetal oxygenation. JAMA. 1987;257:957-961.
10. Farrar HC, Kearns GL. Cocaine: clinical pharmacology and toxicology. J Pediatr. 1989;115:665-675.
11. Gawin FH, Ellinwood EH Jr. Cocaine and other stimulants: actions, abuse and treatment. N Engl J Med. 1988;318:1173-1182.
12. Choi S-J, Mazzio E, Kolta MG, Soliman KFA. Prenatal cocaine exposure affects postnatal dopaminergic systems in various regions of the rat brain. Ann N Y Acad Sci. 1998;844:293-302.
13. Levitt P, Barbe MF, Eagleson KL. Patterning and specification of the cerebral cortex. Annu Rev Neurosci. 1997;20:1-24.
14. Goldman LS, Genel M, Bezman RJ, Slanetz PJ. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. JAMA. 1998;279:1100-1107.
15. Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol Psychiatry. 1997;2:311-313.
16. Amara SG, Kuhar MJ. Neurotransmitter transporters: recent progress. Annu Rev Neurosci. 1993;16:73-93.
17. Volkow ND, Fowler JS, Wang GJ, Ding YS, Gatley SJ. Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies. Eur Neuropsychopharmacol. 2002;12:557-566.
18. Schneider JS, Roeltgen DP. Delayed matching-to-sample, object retrieval, and discrimination reversal deficits in chronic low dose MPTP-treated monkeys. Brain Res. 1993;615:351-354.
19. Strauss DT, Eskes GA, Foster JK. Experimental neuropsychological studies of frontal lobe functions. In: Boller F, Spinnler H, Hendler JA, eds. Handbook of Neuropsychology. Vol 9. New York: Elsevier; 1994:149-185.
20. Garavan H, Morgan RE, Mactutus CF, Levitsky DA, Booze RM, Strupp BJ. Prenatal cocaine exposure impairs selective attention: evidence from serial reversal and extradimensional shift tasks. Behav Neurosci. 2000;114:725-738.
21. Gabriel M, Taylor C. Prenatal exposure to cocaine impairs neuronal coding of attention and discriminative learning. Ann N Y Acad Sci. 1998;846:194-212.
22. Mayes LC, Grillon C, Granger R, Schottenfeld R. Regulation of arousal and attention in preschool children exposed to cocaine prenatally. Ann N Y Acad Sci. 1998;846:126-143.
23. Bandstra ES, Morrow CE, Anthony JC, Accornero VH, Fried PA. Longitudinal investigation of task persistence and sustained attention in children with prenatal cocaine exposure. Neurotoxicol Teratol. 2001;23:545-559.
24. Karmel BZ, Gardner JM. Prenatal cocaine exposure effects on arousal-modulated attention during the neonatal period. Dev Psychobiol. 1996;29:463-480.
25. Leech SL, Richardson GA, Goldschmidt L, Day NL. Prenatal substance exposure: effects on attention and impulsivity of 6-year-olds. Neurotoxicol Teratol. 1999;21:109-118.
26. Richardson GA, Conroy ML, Day NL. Prenatal cocaine exposure: effects on the development of school-age children. Neurotoxicol Teratol. 1996;18:627-634.
27. Bendersky M, Lewis M. Prenatal cocaine exposure and impulse control at two years. Ann N Y Acad Sci. 1998;846:365-367.
28. Hurt H, Brodsky NL, Braitman LE, Giannetta J. Natal status of infants of cocaine users and control subjects: a prospective comparison. J Perinatol. 1995;15:297-304.
29. Hurt H, Brodsky NL, Betancourt L, Braitman LE, Belsky J, Giannetta J. Play behavior in toddlers with in utero cocaine exposure: a prospective, masked, controlled study. J Dev Behav Pediatr. 1996; 17:373-379.
30. Hurt H, Malmud E, Betancourt L, Braitman LE, Brodsky NL, Giannetta J. Children with in utero cocaine exposure do not differ from control subjects on intelligence testing. Arch Pediatr Adolesc Med. 1997;151:1237-1241.
31. Hurt H, Malmud E, Betancourt L, Brodsky NL, Giannetta J. A prospective evaluation of early language development in children with in utero cocaine exposure and in control subjects. J Pediatr. 1997;130:310-312.
32. Hurt H, Malmud E, Braitman LE, Betancourt LM, Brodsky NL, Giannetta JM. Inner-city achievers: who are they? Arch Pediatr Adolesc Med. 1998;152:993-997.
33. Hurt H, Malmud E, Brodsky NL, Giannetta J. Exposure to violence: psychological and academic correlates in child witnesses. Arch Pediatr Adolesc Med. 2001;155:1351-1356.
34. Wechsler D. The Wechsler Preschool and Primary Scale of Intelligence-Revised. San Antonio, TX: The Psychological Corp; 1989.
35. Dickerson Mayes S, Calhoun SL, Crowell EW. Clinical validity and interpretation of the Gordon Diagnostic System in ADHD assessments. Neuropsychol Dev Cogn Sect C Child Neuropsychol. 2001;7: 32-41.
36. Reitan RM, Wolfson D. Neuropsychological Evaluation of Older Children. South Tucson, AZ: Neuropsychology Press; 1992.
37. Manual for the Assessment Data Manager Program (ADM) (computer program). Version. Burlington, VT: University Medical Education Associates; 2002.
38. Gordon M, McClure FD, Aylward GP. The Gordon Diagnostic System: Instruction Manual and Interpretive Guide. 3rd ed. DeWitt, NY: Gordon System, Inc.; 1996.
39. Gordon M, Mettelman BB. The assessment of attention: I. Standardization and reliability of a behavior-based measure. J Clin Psychol. 1988;44:682-690.
40. Reitan RM, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery. Tuscon, AZ: Neuropsychology Press; 1985.
41. Zuckerman B, Frank DA, Hingson R, et al. Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med. 1989;320: 762-768.
42. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum; 1988.
43. Msall ME, Bier J, LaGasse L, Tremont M, Lester B. The vulnerable preschool child: the impact of biomedical and social risks on neurodevelopmental function. Semin Pediatr Neurol. 1998;5:52-61.
44. Bradley RH, Corwyn RF. Socioeconomic status and child development. Annu Rev Psychol. 2002;53:371-399.
45. Sameroff AJ, Seifer R, Baldwin A, Baldwin C. Stability of intelligence from preschool to adolescence: the influence of social and family risk factors. Child Dev. 1993;64:80-97.
46. Huston AC, McLoyd VC, Coll CG. Children and poverty: issues in contemporary research. Child Dev. 1994;65:275-282.
47. Bee HL, Barnard KE, Eyres SJ, et al. Prediction of IQ and language skill from perinatal status, child performance, family characteristics, and mother-infant interaction. Child Dev. 1982;53:1134-1156.
48. Bennett DS, Bendersky M, Lewis M. Children's intellectual and emotional-behavioral adjustment at 4 years as a function of cocaine exposure, maternal characteristics, and environmental risk. Dev Psychol. 2002;38:648-658.
49. Noble KG, Norma MF, Farah MJ. The neurocognitive correlates of socioeconomic status. Paper presented at: Cognitive Neuroscience Society Conference; 2003; New York.
50. Farah M, Savage J, Brodsky N, et al. Association of socioeconomic status with neurocognitive development. Pediatr Res. 2004:55:609A.